RLMD financials
Relmada Therapeutics (RLMD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RLMD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$59.10M | -$57.39M | -1.45 |
| 2024 | $0.00 | $0.00 | -$83.89M | -$79.98M | -2.65 |
| 2023 | $0.00 | $0.00 | -$103.70M | -$98.79M | -3.28 |
| 2022 | $0.00 | $0.00 | -$161.25M | -$157.04M | -5.30 |
| 2021 | $0.00 | $0.00 | -$125.70M | -$125.75M | -7.16 |
| 2020 | $0.00 | $0.00 | -$60.84M | -$59.46M | -3.81 |